Jefferies Group’s Ionis Pharmaceuticals IONS Stock Holding History

Jefferies Group’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q3	$4.67M	Buy	+105,566	New	+$4.67M	0.04%	174
2022 Q1	–	Sell	-44,000	Closed	-$1.34M	–	1142
2021 Q4	$1.34M	Sell	44,000 -137	-0.3%	-$4.17K	0.01%	515
2021 Q3	$1.48M	Sell	44,137 -22,567	-34%	-$757K	0.01%	466
2021 Q2	$2.66M	Buy	66,704 +46,577	+231%	+$1.86M	0.02%	385
2021 Q1	$905K	Buy	20,127 +151	+0.8%	+$6.79K	0.01%	579
2020 Q4	$1.13M	Buy	+19,976	New	+$1.13M	0.01%	505
2020 Q1	–	Sell	-8,223	Closed	-$497K	–	1376
2019 Q4	$497K	Sell	8,223 -22,269	-73%	-$1.35M	﹤0.01%	1019
2019 Q3	$1.83M	Buy	30,492 +12,744	+72%	+$764K	0.01%	561
2019 Q2	$1.14M	Sell	17,748 -2,252	-11%	-$145K	0.01%	648
2019 Q1	$1.62M	Buy	20,000 +3,458	+21%	+$281K	0.01%	530
2018 Q4	$894K	Buy	16,542 +12,442	+303%	+$672K	0.01%	667
2018 Q3	$211K	Sell	4,100 -19,459	-83%	-$1M	﹤0.01%	1361
2018 Q2	$982K	Buy	+23,559	New	+$982K	0.01%	708
2017 Q4	–	Sell	-12,116	Closed	-$614K	–	1775
2017 Q3	$614K	Buy	12,116 +701	+6%	+$35.5K	﹤0.01%	880
2017 Q2	$581K	Sell	11,415 -12,001	-51%	-$611K	﹤0.01%	923
2017 Q1	$941K	Buy	23,416 +3,416	+17%	+$137K	0.01%	700
2016 Q4	$957K	Buy	20,000 +1,188	+6%	+$56.8K	0.01%	651
2016 Q3	$689K	Buy	18,812 +3,156	+20%	+$116K	﹤0.01%	714
2016 Q2	$365K	Sell	15,656 -1,444	-8%	-$33.7K	﹤0.01%	792
2016 Q1	$693K	Sell	17,100 -15,547	-48%	-$630K	﹤0.01%	592
2015 Q4	$2.02M	Buy	32,647 +17,006	+109%	+$1.05M	0.01%	307
2015 Q3	$632K	Sell	15,641 -15,932	-50%	-$644K	﹤0.01%	679
2015 Q2	$1.82M	Buy	+31,573	New	+$1.82M	0.01%	402
2014 Q3	–	Sell	-13,912	Closed	-$479K	–	1507
2014 Q2	$479K	Buy	13,912 +8,020	+136%	+$276K	﹤0.01%	720
2014 Q1	$255K	Buy	5,892 +5,533	+1,541%	+$239K	﹤0.01%	946
2013 Q4	$14K	Buy	+359	New	+$14K	﹤0.01%	1164
2013 Q3	–	Sell	-192	Closed	-$5K	–	1310
2013 Q2	$5K	Buy	+192	New	+$5K	﹤0.01%	1142